Form 4 · Filed Jun 2, 2026, 11:00 PM UTC
AXSM/Axsome Therapeutics, Inc.
Coleman Mark — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | S | sell | 5,537 | $223 | $1,236,910 | 29,603 |
| Jun 1, 2026 | S | sell | 6,000 | $230 | $1,381,800 | 35,140 |
| May 29, 2026 | S | sell | 6,000 | $233 | $1,400,760 | 41,140 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-254038